Create your account

Analyse episodes, create alerts, spot trends before they go mainstream

Already have an account? Sign in

Companies

Sanofi

Mentioned in 8 analyzed podcast episodes across 7 shows

Mentioned On

BioSpaceThe BioHub - by AvetixBiotech HangoutPharma and BioTech DailyVital DawnCulture Apothecary with Alex ClarkGlobal Security Briefing

Episode Mentions

BioSpace

BioSpace · May 13, 2026

Makary’s out at FDA, Sanofi’s priority voucher issues, top exec pay

“Requested removal of T-Zield diabetes drug from FDA's priority review voucher program after staff disagreement”

FDA Commissioner leadership transition and removalRegulatory uncertainty and HHS agency turnoverCommissioner's National Priority Review voucher program
View Analysis
The BioHub - by Avetix

The BioHub - by Avetix · May 12, 2026

Episode 172 - Jonathan Sadeh - EVP, Head of R&D and CMO of Bausch Health

“Early career employer in Dr. Sadeh's 20+ year pharma trajectory across major global organizations”

Career progression in large pharmaceutical organizationsCross-functional collaboration in drug developmentTherapeutic area diversification strategy
View Analysis
Biotech Hangout

Biotech Hangout · May 8, 2026

Episode 182 - May 8, 2026

“Withdrew tiblizumab (type 1 diabetes drug) from FDA Commissioner's Voucher program after disagreement over approval decision”

Biotech Secondary Capital Raises and Market SaturationFDA Regulatory Uncertainty and Commissioner McCary LeadershipM&A Activity in Biotech and Venture Capital Returns
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · May 6, 2026

Sanofi Invests $294M in AI, FDA Approves Auvelity | Pharma and Biotech Daily

“Investing $294 million to expand AI Center of Excellence in Toronto for drug development acceleration”

AI Center of Excellence and Digital Transformation in Drug DevelopmentFDA Approval Processes and Regulatory ModernizationCAR-T Cell Therapy Expansion Beyond Oncology
View Analysis
Pharma and BioTech Daily

Pharma and BioTech Daily · Apr 24, 2026

Regeneron Gene Therapy Approved by FDA: A Game-Changer! | Pharma and Biotech Daily

“Defending Dupixent revenue growth despite R&D setbacks, exemplifying breakthrough biologics driving revenue”

Gene Therapy Regulation and FDA Approval PathwaysHearing Loss Treatment InnovationGLP-1 Receptor Agonists for Type 2 Diabetes
View Analysis
Vital Dawn

Vital Dawn · Apr 23, 2026

Vital Dawn Podcast for Thursday April 23

“European pharmaceutical company trading up on earnings report”

Semiconductor Earnings and AI ExposureSoftware Sector Weakness and Margin PressureTesla Q1 Earnings and CapEx Guidance
View Analysis
Culture Apothecary with Alex Clark

Culture Apothecary with Alex Clark · Feb 24, 2026

How to Heal Eczema Naturally & Brainwash Your Man to Be Healthy | Dr. Ana-Maria Temple, MD

“Manufacturer of RSV vaccine (Arexvy); discussed regarding fast-track approval and limited safety data with concurrent vaccines”

Eczema root cause analysis and natural healing protocolsDupixent and biologic immunosuppressants: safety concerns and alternativesMicronutrient deficiencies (vitamin D, zinc, iron, B12) in chronic childhood illness
View Analysis
Global Security Briefing

Global Security Briefing · Jan 28, 2026

Greenland: A Flashpoint in Transatlantic Relations

“French pharmaceutical company ranking third in insulin production, part of EU supply chain leverage analysis”

Greenland sovereignty and Arctic securityTransatlantic relations and NATO cohesionUS-Denmark bilateral relations
View Analysis